WWHS Biotech Showcases NIR-II POCT at NCLM 2026

WWHS Biotech Showcases NIR-II Immunofluorescence POCT at NCLM 2026, Empowering Primary Care Laboratory Capacity

From September 17 to 19, the 20th National Congress of Laboratory Medicine (NCLM 2026) was held in Wuhan. As one of the most prestigious and influential annual academic events in China's laboratory medicine field, the conference brought together academicians, leading experts, and frontline clinical professionals from home and abroad to explore new pathways for high-quality development of laboratory medicine in the new era.

At this congress, Sansure Biotech presented its comprehensive product matrix and integrated solutions under the core theme of "Precision Foundation, Integrated Diagnosis and Treatment," fully demonstrating its strategic vision of "making precision medicine accessible and bringing diagnostic value to all."

As a core product for primary care capacity building, WWHS Biotech showcased its NIR-II (near-infrared second window) immunofluorescence POCT products at the exhibition. With advantages in technological innovation, ease of operation, and stable results, the products received widespread attention from attending laboratory physicians and distributor partners.

Against the backdrop of national policies explicitly calling for improved primary care laboratory capabilities, WWHS Biotech, as a core product line in the Sansure Biotech ecosystem "multiplier" strategy, works in synergy with molecular POCT, hematology POCT, and other primary care products to jointly enhance primary care laboratory capacity, making precision and convenient testing services accessible to a broader base of primary care patients.